Developmental regulation of neural cell adhesion molecule in human prefrontal cortex by Cox, E. T. et al.
Developmental Regulation of Neural Cell Adhesion Molecule in
Human Prefrontal Cortex
Elizabeth T. Coxa, Leann H. Brennamanb, Karissa L. Gablea, Robert M. Hamera,c, Leisa A.
Glantza,e, Anthony-Samuel LaMantiad,e, Jeffrey A. Liebermanf,g, John H. Gilmorea,e,
Patricia F. Manessb,e, and L. Fredrik Jarskogf,g
a Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599
b Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel
Hill, NC, 27599
c Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599
d Department of Cell and Molecular Physiology, University of North Carolina at Chapel Hill, Chapel
Hill, NC, 27599
e UNC Schizophrenia Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC,
27599
f Department of Psychiatry, Columbia University
g New York State Psychiatric Institute, New York, NY 10032
Abstract
Neural cell adhesion molecule (NCAM) is a membrane-bound cell recognition molecule that exerts
important functions in normal neurodevelopment including cell migration, neurite outgrowth, axon
fasciculation, and synaptic plasticity. Alternative splicing of NCAM mRNA generates three main
protein isoforms: NCAM-180, -140, and -120. Ectodomain shedding of NCAM isoforms can produce
an extracellular 105–115 kDa soluble NCAM fragment (NCAM-EC) and a smaller intracellular
cytoplasmic fragment (NCAM-IC). NCAM also undergoes a unique post-translational modification
in brain by the addition of polysialic acid (PSA)-NCAM. Interestingly, both PSA-NCAM and
NCAM-EC have been implicated in the pathophysiology of schizophrenia. The developmental
expression patterns of the main NCAM isoforms and PSA-NCAM have been described in rodent
brain, but no studies have examined NCAM expression across human cortical development. Western
blotting was used to quantify NCAM in human postmortem prefrontal cortex in 42 individuals
ranging in age from mid-gestation to early adulthood. Each NCAM isoform (NCAM-180, -140, and
-120), post-translational modification (PSA-NCAM) and cleavage fragment (NCAM-EC and
NCAM-IC) demonstrated developmental regulation in frontal cortex. NCAM-180, -140, and -120,
as well as PSA-NCAM, and NCAM-IC all showed strong developmental regulation during fetal and
early postnatal ages, consistent with their identified roles in axon growth and plasticity. NCAM-EC
demonstrated a more gradual increase from the early postnatal period to reach a plateau by early
adolescence, potentially implicating involvement in later developmental processes. In summary, this
study implicates the major NCAM isoforms, PSA- NCAM and proteolytically cleaved NCAM in
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pre- and postnatal development of the human prefrontal cortex. These data provide new insights on
human cortical development and also provide a basis for how altered NCAM signaling during specific
developmental intervals could affect synaptic connectivity and circuit formation, and thereby
contribute to neurodevelopmental disorders.
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Neural cell adhesion molecule (NCAM) is a membrane-bound cell recognition molecule of the
immunoglobulin superfamily. NCAM contributes to normal brain development, with
pleiotropic functions that include cell adhesion, cell migration, neurite outgrowth, axon
fasciculation and guidance, and synaptic plasticity, as well as learning and memory (Maness
and Schachner, 2007). Post-transcriptional modifications of NCAM generate three main
isoforms. NCAM-180 and NCAM-140 are transmembrane forms that have long and short
cytoplasmic domains, respectively. NCAM-180 is found in postsynaptic densities of mature
neurons (Persohn et al., 1989; Fux et al., 2003), while NCAM-140 is expressed in growth cones
and axon shafts of developing neurons (Stork et al., 2000). NCAM-120 is anchored to the cell
membrane via a glycosylphosphatidylinositol (GPI) linkage and expression is primarily in glia
(Noble et al., 1985). However, all NCAM isoforms may support synaptogenesis as synapses
preferentially formed on cells expressing any of the 3 isoforms in culture (Dityatev et al.,
2004). NCAM-180 and NCAM-140 are both highly expressed in the rodent neocortex during
fetal and early postnatal development, and persist into adulthood at lower levels (Chuong and
Edelman, 1984; Gennarini et al., 1986; Oltmann-Norden et al., 2007). NCAM-120 is found at
low levels in fetal rodent brain but increases in early postnatal development and is expressed
at stable levels into adulthood (Gennarini et al., 1986; Brennaman and Maness, 2008).
During embryonic development, each main isoform of NCAM can also undergo post-
translational polysialylation by the addition of α-2,8-linked sialic acid residues to the fifth Ig-
like domain of NCAM. Polysialic acid (PSA)-NCAM has important functions in axon growth,
synaptic plasticity, and synaptogenesis (Bonfanti, 2006). Expression of PSA-NCAM is
developmentally regulated in the rodent cortex, with high fetal levels and rapid postnatal
downregulation (Seki and Arai, 1991; Bonfanti et al., 1992; Oltmann-Norden et al., 2007;
Brennaman and Maness, 2008). PSA-NCAM may also contribute to the pathophysiology of
certain neurodevelopmental disorders. For example, PSA-NCAM immunoreactivity is reduced
in postmortem hippocampal neurons in schizophrenia, potentially contributing to altered
synaptic connectivity (Barbeau et al., 1995). Furthermore, polymorphisms in the promoter of
the major sialyltransferase gene, ST8SiaII/STX, essential for NCAM polysialylation, have
been associated with schizophrenia (Arai et al., 2006).
Transmembrane NCAM isoforms can undergo ectodomain shedding via a disintegrin and
metalloprotease (ADAM) family of proteases, resulting in a 105–115 kDa soluble extracellular
domain fragment (NCAM-EC) and a smaller intracellular domain fragment (NCAM-IC)
(Vawter et al., 2001; Diestel et al., 2005; Hubschmann et al., 2005; Hinkle et al., 2006; Secher,
2008). Transgenic mice that overexpress NCAM-EC in addition to full-length NCAM
demonstrate marked reductions in synaptic terminals in gamma-aminobutyric acid (GABA)
ergic interneurons and pyramidal neurons and have deficits in sensory gating and
amphetamine-induced locomotor activity (Pillai-Nair et al., 2005). The NCAM-EC mouse has
been advanced as a potential model of GABAergic and behavioral deficits in schizophrenia,
and elevated levels of NCAM-EC have been reported in the hippocampus and prefrontal cortex
in schizophrenia (Vawter et al., 1998).
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The pleotropic functions of NCAM are further demonstrated by recent evidence that NCAM
mimetic peptides have been found to enhance synaptic plasticity and produce neuroprotective
effects in animal models (Berezin and Bock, 2008). For example, FGL – an NCAM-derived
fibroblast growth factor receptor agonist – can produce reversal of working memory deficits
in phencyclidine (PCP)-treated rat pups, a model of cognitive deficits with relevance to
schizophrenia (Secher et al., 2009).
Although the developmental expression patterns of the major NCAM isoforms and PSA-
NCAM have been described in rodent brain, we are aware of only one report in human brain
in a study of PSA-NCAM in dentate gyrus (Ni Dhuill et al., 1999). The current study measured
the main isoforms of NCAM (NCAM-180, -140, -120), as well as PSA-NCAM, NCAM-EC
and NCAM-IC proteins in human prefrontal cortex from mid-gestation into early adulthood.
Insight into the expression patterns of NCAM protein in human cortex across the first 3 decades
of life can inform on diverse developmental processes in human brain including neuronal
migration, synaptogenesis, and synaptic plasticity. Identifying the patterns of NCAM protein
expression can help identify windows during which NCAM signaling may be vulnerable to
developmental perturbation and provide a basis for understanding the pathophysiology of
neurodevelopmental disorders such as schizophrenia.
EXPERIMENTAL PROCEDURES
Postmortem samples and tissue preparation
This study was approved by the University of North Carolina School of Medicine Institutional
Review Board. Human tissue was obtained from the Brain and Tissue Bank for Developmental
Disorders at the University of Maryland, Baltimore, Maryland. Coronally cut slabs of
prefrontal cortex (areas 9/46) from 42 human postmortem brains were frozen at autopsy and
stored at −80°C until use. Gross and microscopic examination by a neuropathologist revealed
no evidence of central nervous system pathology. Subjects had no known history of
neurological or psychiatric illness, including substance abuse. Subjects ranged in age from 18
gestational weeks to 25 years. A priori, the subjects were divided into seven age groups: fetal
(n=6), 0–12 months (n=4), 1–5 years (n=6), 6–10 years (n=6), 11–15 years (n=9), 16–20 years
(n=4), and 21–25 years (n=7). For subject demographics, see Table 1.
Tissue was prepared as described previously (Jarskog and Gilmore, 2000). Briefly, the tissue
was homogenized (1:10, wt:vol) for 30 seconds on ice in homogenization buffer (50 mM Tris-
HCl buffer (pH 7.4), 0.6 M NaCl, 0.2% Triton X-100, 1 mM benzamidine, 0.1 mM
benzethonium chloride, and 0.1 mM PMSF) and then sonicated at 10mV for 10 seconds. This
method measures both soluble and membrane-bound NCAM isoforms. Samples were
centrifuged for 15 minutes at 15,000 × g and at 4°C and supernatants were assayed for total
protein using the bicinchronic acid method (Micro BCA Protein Assay Kit, Pierce Chemical,
Rockford, IL).
Western blotting
Samples were separated on 4% (NCAM-180, -140, -120, PSA-NCAM) or 12% (NCAM-IC)
10-well Tris-glycine polyacrylamide gels (NOVEX, San Diego, CA) or 7.5% (NCAM-EC)
15-well Tris-HCl polyacrylamide gels (BioRad, Hercules, CA) by adapting previously
established methods (Hochstrasser et al., 1988; Vawter et al., 1998; Jarskog and Gilmore,
2000). Equal amounts of total protein (10 μg for main isoforms and NCAM-EC, 100 μg for
PSA-NCAM, and 55μg for NCAM-IC) were loaded on gels with a molecular weight marker
(MagicMark XP, Invitrogen) and run at 25°C for 90 minutes at 125V, except for NCAM-EC
gels that were run on ice for 35 minutes at 300V. All samples were run in triplicate on separate
gels. Proteins were then transferred to polyvinylidene difluoride (PVDF) membranes
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(Immunobilon-P, Millipore, MA) at 25V for 90 minutes. Complete transfers were verified by
membrane staining with Ponceau S (data not shown). Nonspecific protein binding was blocked
for 1 hour at room temperature in 5% dry milk. Membranes were incubated with primary
antibody overnight at 4°C as follows: rabbit anti-human polyclonal NCAM (1:2000, Santa
Cruz Biotechnology, Santa Cruz, CA) for main isoforms and NCAM-EC, mouse anti-
meningococcal monoclonal PSA-NCAM (1:200, Chemicon, Temecula, CA), and mouse anti-
rat monoclonal NCAM (0B11, 1:250, Sigma, St. Louis, MO) for NCAM-IC in 5% milk/TBST.
Membranes were then incubated with secondary antibody for 90 minutes at 25°C as follows:
1:3000 anti-rabbit for main isoforms and NCAM-EC, 1:1000 anti-mouse for PSA-NCAM, and
1:3000 anti-mouse for NCAM-IC in 5% milk/TBST. Membranes were developed by
chemiluminescence (ECL, Amersham Pharmacia) and protein bands were detected on
radiographic film (Hyperfilm ECL, Amersham Pharmacia). Images were scanned (Epson
Expression 1680) into Adobe Photoshop 7.0 (Adobe systems, San Jose, CA) and densitometry
was performed using the Bioquant Nova Prime system.
Membranes were stripped using IgG Elution Buffer (Fisher Scientific) and reprobed for anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1:20000, Imgenex, San Diego, CA).
The density of each NCAM isoform was normalized to GAPDH. Separately, increasing
amounts of total protein were applied to a set of gels to ascertain that the samples fell within
the linear range of the densitometric curve for each protein.
Postmortem stability of NCAM isoforms
Thirteen 150–200g male Sprague Dawley rats (Zivic-Miller, Allison Park, PA) were
anaesthetized with ether, decapitated, and separated into two groups. In the first group (n=6),
frontal cortex was dissected and frozen immediately at −80°C, while in the second group (n=7)
heads were kept at 25°C for 6 hours and then at 4°C for 18 hours before dissection and freezing.
This experimental paradigm was used to approximate the postmortem condition for human
brain tissue used in the current study since most subjects were brought to the medical examiner
and placed in refrigerated storage prior to autopsy and brain tissue was dissected out and frozen
within 24 hours after death. All rat cortical tissue was homogenized, sonicated, and Western
blots analyzed as described above for human tissue. All primary antibodies recognized NCAM
isoforms of rat and human origin.
pH Measurement
pH values for all brain tissue was ≥ 5.8, using previously established methods for pH
determination (Romanczyk et al., 2002; Salimi et al., 2008). Briefly, about 250 mg cortical
tissue was dissected from each brain sample and pulverized over an isopentane/dry ice slurry.
Sterile water was added to the frozen powder (1:10 wt:vol) and homogenized for 10–15 s at
0°C. pH was measured with a Ross Sure Flow pH meter and Orion Thermo Ross Semimer
perphect pH electrode.
Statistics
Statistical analysis was performed using GraphPad Prism Version 4.01 (GraphPad Software,
San Diego, CA) and SAS version 9.1 (SAS, Cary, NC). Western blot data were analyzed by
one-way analysis of variance (ANOVA) across age groups with significance set at p<0.05.
Post-hoc Tukey’s Multiple Comparison Test were performed with two-tailed p-values
considered significant at <0.05. In a secondary analysis, NCAM values were regressed with
age using linear and linear plus quadratic models with PMI and pH as covariates. The
postmortem stability data was analyzed with an unpaired Student’s t-test, with two-tailed p-
values considered significant at p<0.05.
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Mean sample pH did not differ across the age groups by ANOVA (F=1.323, df=6, 41, p=0.273),
see Table 1. PMI did vary significantly across the age groups by ANOVA (F=9.704, df=6, 41,
p<0.0001), see Table 1. Post hoc Tukey’s multiple comparison testing showed that the fetal
group had lower PMI compared to each of the postnatal groups except for the 0–12 month
group. The 0–12 month group also had lower PMI compared to the 6–10 and 11–15 year groups.
In order to account for the potential confounding effects of pH and PMI, these variables were
used as covariates in our statistical model.
Immunoreactive bands for each of the NCAM isoforms and cleavage fragments were identified
by Western blotting in human prefrontal cortex, see Figure 1. Each NCAM protein
demonstrated a distinct pattern of developmental regulation from mid-gestation into early
adulthood. A priori, the brain samples were batched into seven age groups: fetal, 0–12 months,
1–5 years, 6–10 years, 11–15 years, 16–20 years, and 21–25 years. Subjects have been batched
into similar age groups in previous studies of human cortical development (Romanczyk et al.,
2002;Webster et al., 2002;Glantz et al., 2007). Batching subjects into age groups can help
identify changes in the protein of interest during specific neurodevelopmental events such as
axo-dendritic growth in the prenatal period, synaptogenesis during the early postnatal period,
and synaptic elimination in early to mid adolescence.
In order to quantitate immunoreactive bands across a wide age range, it is important to
normalize data to a gene product with stable levels across the same age interval. While both
β-actin and α-tubulin bands exhibited substantial age-dependent changes (data not shown),
GAPDH immunoreactive bands were remarkably stable from mid-gestation into early
adulthood, by ANOVA (F=1.242, df=6, 41, p=0.309), see Figures 1,2. GAPDH was used to
normalize data for each of the NCAM proteins.
Intact NCAM Isoforms (NCAM-180, NCAM-140, NCAM-120)
The antibody used for the main NCAM isoforms revealed immunoreactive bands at 180, 140
and 120 kDa molecular weights in nearly every cortical sample, see Figure 1. The highest
NCAM-180 expression was found in fetal cortex although robust levels were also found in
postnatal cortex through early adulthood, see Figures 1 and 3a. Similar to two other studies of
NCAM isoforms in human frontal cortex, one or more weaker bands also appeared below the
main 180 kDa band, likely representing heterogeneity of the NCAM-180 isoform (Barbeau et
al., 1995;Vawter et al., 1998). Differences in levels of NCAM-180 showed a significant effect
of age by ANOVA (F=3.674, df=6, 41, p=0.0062), see Figure 3A. A post hoc Tukey’s multiple
comparison test showed that the 1–5 year group (p<0.05) and the adult group (p<0.05) had
lower NCAM-180 compared to the fetal group. To covary for the potential effects of PMI and
tissue pH on these findings, a secondary regression analysis across all individual samples was
also performed. A weak negative linear correlation emerged between age and NCAM-180
(F=4.62, p=0.0378, R-Square=0.1035). A similar relationship remained after covarying for
PMI and pH (F=2.24, p=0.0989, R-square=0.1505).
The developmental pattern of NCAM-140 was similar to NCAM-180, see Figure 1. The highest
levels of NCAM-140 occurred in fetal and early postnatal subjects, although strong
immunoreactive bands for NCAM-140 persisted into adulthood. In post hoc testing,
NCAM-140 in the 0–12 month group was higher than in each the older age groups and
NCAM-140 demonstrated a significant effect of age by ANOVA (F=6.497, df=6, 41,
p<0.0001), see Figure 3B. A regression analysis across individual subjects showed a negative
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linear correlation between age and NCAM-140 (F=10.42, p=0.0024, R-Square=0.2078) that
remained significant after covarying for PMI and pH (F=4.80, p=0.0063, R-square=0.2747).
The pattern of expression of NCAM-120 was distinct from NCAM-180 and NCAM-140 in
that NCAM-120 was almost absent in fetal cortex, see Figure 1. Furthermore, NCAM-120
levels were substantially higher in the early postnatal group and remained elevated into
adulthood. NCAM-120 demonstrated a significant effect of age by ANOVA (F=5.311, df=6,
41, p=0.0006), see Figure 3C. In post hoc testing, NCAM-120 in the fetal group was lower
than in the 0–12 month (p<0.01), 6–10 year (p<0.05), 11–15 year (p<0.001), and 21–25 year
(p<0.05) groups. Across individual samples, NCAM-120 showed a positive nonlinear
relationship with age (F=5.33, p=0.009, R-Square=0.2146), a relationship that remained
significant after covarying for PMI and pH (F=5.31, p=0.0018, R-square=0.3645).
PSA-NCAM
High PSA-NCAM levels were strikingly associated with the earliest stages of cortical
development, see Figure 1. Fetal samples were characterized by a broad immunoreactive band
at 180 kDa and another strong band around 140 kDa. While the identity of the band at 140 kDa
is uncertain, it may reflect differing length sialic acid chains or possibly a cleavage fragment.
PSA-NCAM immunoreactive bands in all postnatal samples were much weaker than in the
fetal samples. Fetal PSA-NCAM was higher than each of the older age groups (p<0.001),
ranging from 5-fold higher compared to the 0–12 month group to greater than 30-fold higher
compared to the adult group. PSA-NCAM showed a robust effect of age by ANOVA (F=20.57,
df=6, 41, p<0.0001), see Figure 4. Across individual samples, PSA-NCAM showed a negative
non-linear relationship with age (F=15.76, p<0.0001, R-Square=0.4470) that remained
significant after covarying for PMI and pH (F=9.16, p<0.0001, R-square=0.4976).
Proteolytic Fragments of NCAM (NCAM-EC, NCAM-IC)
NCAM-EC has previously been found to migrate as a broad band in the 105–115 kDa range
in human cortex (Vawter et al., 1998). A 105–115 kDa band separated from a 120 kDa band
(NCAM-120) in most of the postnatal samples, see Figure 1. NCAM-EC bands were not
visualized in most fetal samples, but they were detected with gradually increasing intensity in
the infant and childhood samples. NCAM-EC reached a plateau in late childhood and early
adolescence. NCAM-EC showed a significant effect of age by ANOVA (F=7.264, df=6, 41,
p<0.0001), see Figure 5A. Across all individual samples, NCAM-EC showed a positive, linear
correlation with age (F=31.52, p<0.0001, R-Square=0.4407) that remained significant after
covarying for PMI and pH (F=11.63, p<0.0001, R-square=0.4787). To explore the relationship
between NCAM-EC and the transmembrane NCAM isoforms, linear regression analyses were
performed. While visual inspection of the levels of NCAM-180 versus NCAM-EC and
NCAM-140 versus NCAM-EC suggested weak negative relationships, the correlations were
not significant (NCAM-180 vs NCAM-EC, F=2.22, p=0.144, R-square=0.05254; NCAM-140
vs NCAM-EC, F=1.68, p=0.202, R-square=0.0404), see Figures 5C and 5D.
Immunoblotting for NCAM-IC demonstrated a band migrating to 30 kDa, consistent with the
cytoplasmic domain of NCAM-140. Non-specific binding in the 70–80 kDa region prevented
resolution of a potential intracellular fragment of NCAM-180. The highest NCAM-IC (30 kDa)
levels were seen in the fetal and early postnatal cortex (0–12 month group), after which NCAM-
IC was uniformly low. NCAM-IC in the 0–12 month group was significantly higher than each
of the older groups in posthoc testing. NCAM-IC demonstrated a significant effect of age by
ANOVA (F=8.529, df=6, 41, p<0.0001), see Figure 5B. Across individual samples, NCAM-
IC showed a negative, non-linear relationship with age (F=9.85, p=0.0003, R-Square=0.3356)
that remained significant after covarying for PMI and pH (F=7.17, p=0.0002, R-
square=0.4368).
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Each of the NCAM proteins revealed good postmortem stability in a rat model. In this model,
animals were sacrificed and frontal cortices were either dissected and frozen immediately or
animals were kept at 25°C for 6 hours and then at 4°C for 18 hours before dissection and
freezing. This paradigm modeled the typical postmortem course of many of the human subjects
in this collection. Since none of the NCAM species showed a statistically significant change
after a 24 hour PMI, it reduces the likelihood that the findings are significantly confounded by
non-specific protein degradation of NCAM species. The numerical percentage changes and
associated p values at 24 hours PMI compared to baseline were as follows: NCAM-180 (−25%,
p=0.191), NCAM-140 (−1%, p=0.840), NCAM-120 (−17%, p=0.539), NCAM-EC (+18%,
p=0.783), NCAM-IC (−15%, p=0.211), and PSA-NCAM (−12%, p=0.597).
DISCUSSION
This study is the first to examine major NCAM isoforms and proteolytic cleavage products in
human cortex across development. The study demonstrated that NCAM-180, NCAM-140,
NCAM-120, PSA-NCAM, and transmembrane-cleaved NCAM fragments are
developmentally regulated from mid-gestation into early adulthood in human prefrontal cortex,
see Figure 6 for summary comparison. These data represent the first analysis of NCAM in
human prefrontal cortex across development, and suggest important roles for NCAM in both
early and later stages of development.
Expression of NCAM-180 and -140 isoforms were highest in fetal and infant cortex but each
of the postnatal age groups showed substantial immunoreactivity into adulthood. This pattern
is in general agreement with the developmental expression of NCAM-180 and -140 seen in
rodent cortex (Chuong and Edelman, 1984). High level of NCAM-140 in early life is consistent
with its localization to axon shafts and migratory growth cones of developing neurons and its
role in regulating neurite outgrowth (Persohn et al., 1989; Stork et al., 2000). In contrast,
NCAM-180 levels declined somewhat less than NCAM-140 across development, see Figure
3. The pattern of persistent NCAM-180 expression into adulthood is consistent with evidence
that it is enriched in postsynaptic densities and contributes to synaptic plasticity, especially in
mature neurons (Tomasiewicz et al., 1993; Wood et al., 1998; Dityatev et al., 2000). Notably,
NCAM-180 expression appeared to decrease across adolescence into early adulthood. Given
that NCAM-180 is enriched in postsynaptic densities, this developmental pattern across
adolescence might in part reflect large-scale synaptic elimination as has been demonstrated in
adolescent prefrontal cortex in both human (Huttenlocher and Dabholkar, 1997; Glantz et al.,
2007) and non-human primate brains (Rakic et al., 1986; Anderson et al., 1995).
NCAM-120 was also developmentally regulated in the prefrontal cortex; however, its
expression was virtually absent in fetal cortex followed by a robust increase in the infant cortex
that remained elevated into adulthood. These data are corroborated by studies of NCAM-120
in mouse cortex and are unlikely to be the consequence of postmortem degradation. In mouse
cortex, NCAM-120 is not expressed at high levels until postnatal development and its
expression appears to be limited to cells of glial origin (Noble et al., 1985; Gennarini et al.,
1986). Given that gliogenesis in human cortex is most active in the second half of gestation
(Mrzljak et al., 1992; de Graaf-Peters and Hadders-Algra, 2006) and that the fetal samples in
the current study were slightly under 20 gestational weeks, absence of NCAM-120 in the fetal
group but presence in the earliest postnatal samples is consistent with data from mouse studies.
The findings also suggest an important role for NCAM-120 in the adult cortex.
Each of the 3 main isoforms of NCAM can be post-translationally modified by PSA.
Polysialylation of NCAM decreases NCAM-mediated cell adhesion, thereby promoting axon
outgrowth and cell migration (Bruses and Rutishauser, 2001). This effect occurs via direct
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steric inhibition of membrane-membrane apposition (Fujimoto et al., 2001). In the current
study, PSA-immunoreactivity was observed in two broad bands that was highest in fetal cortex
and then declined sharply after birth with stable low expression into adulthood. In fact, the
subjects that were older than 3 weeks of age had PSA-NCAM expression that was comparable
to adult levels, suggesting that postnatal downregulation of PSA-NCAM occurs rapidly during
a narrow perinatal window preceding the onset of large-scale cortical synaptogenesis. The
mechanism(s) that regulate PSA-NCAM levels across development are not currently
understood.
NCAM-EC demonstrated a relatively slow and progressive increase starting in infancy and
reaching a plateau in early adolescence, indicating that the shedding process is also
developmentally regulated. While speculative, the apparent inverse relationship between
NCAM-EC and both NCAM-140 and NCAM-180 suggests that these transmembrane isoforms
could contribute to NCAM-EC in human cortex. In support of this hypothesis, synaptosomal
preparations from human occipital cortex demonstrated an inverse relationship between
NCAM-180 and NCAM-EC levels (Vawter et al., 2001). Likewise, studies of fibroblastoid
cell lines transfected with individual NCAM isoforms have demonstrated that
metalloproteinase-inducible shedding is associated with lower levels of full-length NCAM
isoforms and higher levels of NCAM-EC (Diestel et al., 2005; Hubschmann et al., 2005; Hinkle
et al., 2006). Future studies of ADAM protease expression and activity in human cortical
development could further our understanding of NCAM-EC regulation.
Functionally, the importance of regulating NCAM-EC levels is demonstrated in transgenic
mice that overexpress NCAM-EC, in which cortical neurons display reduced neurite outgrowth
and branching and apical dendritic spines are reduced (Pillai-Nair et al., 2005; Brennaman and
Maness, 2008), indicating that excessive shedding prevents normal neuronal architecture.
NCAM-EC transgenic mice also show reduced GABAergic and excitatory synaptic contacts
and associated sensory gating deficits (Pillai-Nair et al., 2005), suggesting an important role
for NCAM-EC in synapse development as well. Since NCAM-EC appears to have a dominant
negative effect on synapse development, the evidence for low NCAM-EC levels in infant cortex
is consistent with large-scale cortical synpatogenesis during the first year of life. The
subsequent rise in NCAM-EC levels may contribute to regulating synaptic formation in later
development and the persistence of NCAM-EC into adulthood suggests it may exert an
important function in synaptic maintenance and stability. One study has found changes in
NCAM-EC levels in schizophrenia, with elevated levels in frontal cortex and hippocampus
(Vawter et al., 1998). The current findings lend support to the hypothesis that changes in normal
developmental regulation of NCAM-EC shedding represents a potential mechanism that could
contribute to altered synaptic connectivity in schizophrenia.
This study demonstrated that NCAM-IC (30 kDa) is also developmentally regulated in human
frontal cortex, with high levels in fetal and early postnatal period and then decreasing to a stable
plateau after about one year of age. Early development may represent a window in which
ectodomain shedding begins to yield NCAM-IC, implicating cleavage in the development of
normal cortical cytoarchitecture. Support for this notion comes from cell culture studies which
have demonstrated that NCAM-IC (30 kDa) competitively interacts with the non-receptor
tyrosine kinase p59fyn to inhibit neurite outgrowth and cell migration (Prag et al., 2002; Buttner
et al., 2004), while the 80 kDa fragment competes with NCAM-180 for spectrin to promote
neurite outgrowth (Buttner et al., 2004). On the other hand, shedding downregulates PSA-
NCAM from the cell surface, enabling interactions of noncleaved NCAM with heterophilic or
homophilic receptors, and other molecules that promote synaptogenesis. Somewhat
paradoxically, our study found a weak inverse relationship between NCAM-IC and NCAM-
EC levels. One possibility is that the main source of NCAM-EC could shift from NCAM-140
to another NCAM isoform across development. This could yield progressively less NCAM-
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IC (30 kDa), potentially generating an ~80 kDa NCAM-IC fragment derived from NCAM180
that we were unable to resolve, even as NCAM-EC remains elevated. Alternatively, a secreted
isoform of NCAM (NCAM-SEC, 108–115 kDa) may not be readily distinguishable from
NCAM-EC (Poltorak et al., 1996; Vawter et al., 1999), and could contribute to higher NCAM-
EC levels across development. Differential clearance rates of NCAM-EC and NCAM-IC could
also contribute to their apparent inverse relationship.
A number of potentially confounding variables were considered in this study. First, mean PMI
differed across the groups by ANOVA, due primarily to the short PMI in the fetal group.
However, mean tissue pH did not vary across the age groups and evidence suggests that pH is
a better predictor than PMI of protein and mRNA stability in postmortem brain tissue (Harrison
et al., 1995). Several methods were used to assess the impact of PMI and pH on the results.
Applying linear and quadratic regression analysis to each NCAM protein and then covarying
for PMI and pH demonstrated that neither PMI nor pH had a significant effect on the NCAM
findings. To further examine the potential impact of PMI on NCAM, a postmortem stability
study was performed using a rat model to approximate the human postmortem condition. None
of the NCAM isoforms or cleavage products showed significant changes over a 24 hour PMI,
indicating that the results were not likely to have been influenced by postmortem degradation.
Second, the distribution of subject ages was uneven within each of the age groups. For example,
the fetal group was represented solely by mid-second trimester subjects, while the 0–12 month
group had primarily neonates. In a future study, more subjects and a more even distribution of
subjects for targeted age intervals may help to more precisely identify the inflection points of
NCAM regulation. Other potential confounds include undiagnosed physical and psychiatric
disorders (including substance abuse), dietary issues and effects of medications that subjects
could have been taking.
In conclusion, each of the NCAM proteins and cleavage products studied – NCAM-180,
NCAM-140, NCAM-120, PSA-NCAM, NCAM-EC and NCAM-IC – were developmentally
regulated in human frontal cortex. For the main isoforms (NCAM-180, -140, and -120) and
PSA-NCAM, the developmental patterns in human cortex were similar to patterns found in
rodent studies. Most up- or down-regulation occurred across the fetal and early postnatal ages,
but NCAM-EC also demonstrated modest regulation across adolescence. These results support
the hypothesis that NCAM exerts important roles in axonal/dendritic growth and synaptic
plasticity in early human cortical development. Beyond informing on normal developmental
processes, these data suggest developmental age ranges during which NCAM signaling might
be particularly susceptible to perturbation and, in turn, contribute to altered neurodevelopment.
The specific mechanisms that govern the developmental trajectories of each NCAM isoform
remain unknown but are likely to be highly complex and dependent upon cell- and location-
specific factors. Immunohistochemical approaches will be used in future studies to localize
NCAM isoform expression to specific cell types to further enhance our understanding of the
role of NCAM signaling in normal and altered neurodevelopment.
Acknowledgments
This study was supported in part by NIMH grants MH-01752 (LFJ) and MH-64065 (JHG, PFM).
Abbreviations
NCAM  
neural cell adhesion molecule
PSA  
polysialic acid
Cox et al. Page 9






























Anderson SA, Classey JD, Conde F, Lund JS, Lewis DA. Synchronous development of pyramidal neuron
dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of
monkey prefrontal cortex. Neuroscience 1995;67:7–22. [PubMed: 7477911]
Arai M, Yamada K, Toyota T, Obata N, Haga S, Yoshida Y, Nakamura K, Minabe Y, Ujike H, Sora I,
Ikeda K, Mori N, Yoshikawa T, Itokawa M. Association between polymorphisms in the promoter
region of the sialyltransferase 8B (SIAT8B) gene and schizophrenia. Biol Psychiatry 2006;59:652–
659. [PubMed: 16229822]
Barbeau D, Liang JJ, Robitalille Y, Quirion R, Srivastava LK. Decreased expression of the embryonic
form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A
1995;92:2785–2789. [PubMed: 7708724]
Berezin V, Bock E. NCAM Mimetic Peptides: An Update. Neurochem Res. 2008
Bonfanti L. PSA-NCAM in mammalian structural plasticity and neurogenesis. Prog Neurobiol
2006;80:129–164. [PubMed: 17029752]
Bonfanti L, Olive S, Poulain DA, Theodosis DT. Mapping of the distribution of polysialylated neural
cell adhesion molecule throughout the central nervous system of the adult rat: an immunohistochemical
study. Neuroscience 1992;49:419–436. [PubMed: 1436474]
Brennaman LH, Maness PF. Developmental regulation of GABAergic interneuron branching and
synaptic development in the prefrontal cortex by soluble neural cell adhesion molecule. Mol Cell
Neurosci 2008;37:781–793. [PubMed: 18289872]
Bruses JL, Rutishauser U. Roles, regulation, and mechanism of polysialic acid function during neural
development. Biochimie 2001;83:635–643. [PubMed: 11522392]
Buttner B, Reutter W, Horstkorte R. Cytoplasmic domain of NCAM 180 reduces NCAM-mediated
neurite outgrowth. J Neurosci Res 2004;75:854–860. [PubMed: 14994346]
Chuong CM, Edelman GM. Alterations in neural cell adhesion molecules during development of different
regions of the nervous system. J Neurosci 1984;4:2354–2368. [PubMed: 6481452]
de Graaf-Peters VB, Hadders-Algra M. Ontogeny of the human central nervous system: what is happening
when? Early Hum Dev 2006;82:257–266. [PubMed: 16360292]
Diestel S, Hinkle CL, Schmitz B, Maness PF. NCAM140 stimulates integrin-dependent cell migration
by ectodomain shedding. J Neurochem 2005;95:1777–1784. [PubMed: 16277615]
Cox et al. Page 10













Dityatev A, Dityateva G, Schachner M. Synaptic strength as a function of post- versus presynaptic
expression of the neural cell adhesion molecule NCAM. Neuron 2000;26:207–217. [PubMed:
10798405]
Dityatev A, Dityateva G, Sytnyk V, Delling M, Toni N, Nikonenko I, Muller D, Schachner M.
Polysialylated neural cell adhesion molecule promotes remodeling and formation of hippocampal
synapses. J Neurosci 2004;24:9372–9382. [PubMed: 15496673]
Fujimoto I, Bruses JL, Rutishauser U. Regulation of cell adhesion by polysialic acid. Effects on cadherin,
immunoglobulin cell adhesion molecule, and integrin function and independence from neural cell
adhesion molecule binding or signaling activity. J Biol Chem 2001;276:31745–31751. [PubMed:
11425861]
Fux CM, Krug M, Dityatev A, Schuster T, Schachner M. NCAM180 and glutamate receptor subtypes in
potentiated spine synapses: an immunogold electron microscopic study. Mol Cell Neurosci
2003;24:939–950. [PubMed: 14697660]
Gennarini G, Hirsch MR, He HT, Hirn M, Finne J, Goridis C. Differential expression of mouse neural
cell-adhesion molecule (N-CAM) mRNA species during brain development and in neural cell lines.
J Neurosci 1986;6:1983–1990. [PubMed: 3734870]
Glantz LA, Gilmore JH, Hamer RM, Lieberman JA, Jarskog LF. Synaptophysin and postsynaptic density
protein 95 in the human prefrontal cortex from mid-gestation into early adulthood. Neuroscience
2007;149:582–591. [PubMed: 17916412]
Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC. The relative importance
of premortem acidosis and postmortem interval for human brain gene expression studies: selective
mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995;200:151–154.
[PubMed: 9064599]
Hinkle CL, Diestel S, Lieberman J, Maness PF. Metalloprotease-induced ectodomain shedding of neural
cell adhesion molecule (NCAM). J Neurobiol 2006;66:1378–1395. [PubMed: 16967505]
Hochstrasser DF, Harrington MG, Hochstrasser AC, Miller MJ, Merril CR. Methods for increasing the
resolution of two-dimensional protein electrophoresis. Anal Biochem 1988;173:424–435. [PubMed:
3189820]
Hubschmann MV, Skladchikova G, Bock E, Berezin V. Neural cell adhesion molecule function is
regulated by metalloproteinase-mediated ectodomain release. J Neurosci Res 2005;80:826–837.
[PubMed: 15884014]
Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J
Comp Neurol 1997;387:167–178. [PubMed: 9336221]
Jarskog LF, Gilmore JH. Developmental expression of Bcl-2 protein in human cortex. Brain Res Dev
Brain Res 2000;119:225–230.
Maness PF, Schachner M. Neural recognition molecules of the immunoglobulin superfamily: signaling
transducers of axon guidance and neuronal migration. Nat Neurosci 2007;10:19–26. [PubMed:
17189949]
Mrzljak L, Uylings HB, Kostovic I, van Eden CG. Prenatal development of neurons in the human
prefrontal cortex. II. A quantitative Golgi study. J Comp Neurol 1992;316:485–496. [PubMed:
1577996]
Ni Dhuill CM, Fox GB, Pittock SJ, O’Connell AW, Murphy KJ, Regan CM. Polysialylated neural cell
adhesion molecule expression in the dentate gyrus of the human hippocampal formation from infancy
to old age. J Neurosci Res 1999;55:99–106. [PubMed: 9890438]
Noble M, Albrechtsen M, Moller C, Lyles J, Bock E, Goridis C, Watanabe M, Rutishauser U. Glial cells
express N-CAM/D2-CAM-like polypeptides in vitro. Nature 1985;316:725–728. [PubMed:
2412126]
Oltmann-Norden I, Galuska SP, Hildebrandt H, Geyer R, Gerardy-Schahn R, Geyer H, Muhlenhoff M.
Impact of the polysialyltransferases ST8SiaII and ST8SiaIV on polysialic acid synthesis during
postnatal mouse brain development. J Biol Chem. 2007
Persohn E, Pollerberg GE, Schachner M. Immunoelectron-microscopic localization of the 180 kD
component of the neural cell adhesion molecule N-CAM in postsynaptic membranes. J Comp Neurol
1989;288:92–100. [PubMed: 2794140]
Cox et al. Page 11













Pillai-Nair N, Panicker AK, Rodriguiz RM, Gilmore KL, Demyanenko GP, Huang JZ, Wetsel WC,
Maness PF. Neural cell adhesion molecule-secreting transgenic mice display abnormalities in
GABAergic interneurons and alterations in behavior. J Neurosci 2005;25:4659–4671. [PubMed:
15872114]
Poltorak M, Frye MA, Wright R, Hemperly JJ, George MS, Pazzaglia PJ, Jerrels SA, Post RM, Freed
WJ. Increased neural cell adhesion molecule in the CSF of patients with mood disorder. J Neurochem
1996;66:1532–1538. [PubMed: 8627309]
Prag S, Lepekhin EA, Kolkova K, Hartmann-Petersen R, Kawa A, Walmod PS, Belman V, Gallagher
HC, Berezin V, Bock E, Pedersen N. NCAM regulates cell motility. J Cell Sci 2002;115:283–292.
[PubMed: 11839780]
Rakic P, Bourgeois JP, Eckenhoff MF, Zecevic N, Goldman-Rakic PS. Concurrent overproduction of
synapses in diverse regions of the primate cerebral cortex. Science 1986;232:232–235. [PubMed:
3952506]
Romanczyk TB, Weickert CS, Webster MJ, Herman MM, Akil M, Kleinman JE. Alterations in trkB
mRNA in the human prefrontal cortex throughout the lifespan. Eur J Neurosci 2002;15:269–280.
[PubMed: 11849294]
Salimi K, Glantz LA, Hamer RM, German TT, Gilmore JH, Jarskog LF. Regulation of complexin 1 and
complexin 2 in the developing human prefrontal cortex. Synapse 2008;62:273–282. [PubMed:
18240322]
Secher T. Soluble NCAM. Neurochem Res. 2008[Epub ahead of print]
Secher T, Berezin V, Bock E, Glenthoj B. Effect of an NCAM mimetic peptide FGL on impairment in
spatial learning and memory after neonatal phencyclidine treatment in rats. Behav Brain Res
2009;199:288–297. [PubMed: 19133297]
Seki T, Arai Y. Expression of highly polysialylated NCAM in the neocortex and piriform cortex of the
developing and the adult rat. Anat Embryol (Berl) 1991;184:395–401. [PubMed: 1952111]
Stork O, Welzl H, Wolfer D, Schuster T, Mantei N, Stork S, Hoyer D, Lipp H, Obata K, Schachner M.
Recovery of emotional behaviour in neural cell adhesion molecule (NCAM) null mutant mice through
transgenic expression of NCAM180. Eur J Neurosci 2000;12:3291–3306. [PubMed: 10998113]
Tomasiewicz H, Ono K, Yee D, Thompson C, Goridis C, Rutishauser U, Magnuson T. Genetic deletion
of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central
nervous system. Neuron 1993;11:1163–1174. [PubMed: 8274281]
Vawter MP, Cannon-Spoor HE, Hemperly JJ, Hyde TM, VanderPutten DM, Kleinman JE, Freed WJ.
Abnormal expression of cell recognition molecules in schizophrenia. Exp Neurol 1998;149:424–432.
[PubMed: 9500955]
Vawter MP, Howard AL, Hyde TM, Kleinman JE, Freed WJ. Alterations of hippocampal secreted N-
CAM in bipolar disorder and synaptophysin in schizophrenia. Mol Psychiatry 1999;4:467–475.
[PubMed: 10523820]
Vawter MP, Usen N, Thatcher L, Ladenheim B, Zhang P, VanderPutten DM, Conant K, Herman MM,
van Kammen DP, Sedvall G, Garver DL, Freed WJ. Characterization of human cleaved N-CAM and
association with schizophrenia. Exp Neurol 2001;172:29–46. [PubMed: 11681838]
Webster MJ, Weickert CS, Herman MM, Kleinman JE. BDNF mRNA expression during postnatal
development, maturation and aging of the human prefrontal cortex. Brain Res Dev Brain Res
2002;139:139–150.
Wood GK, Tomasiewicz H, Rutishauser U, Magnuson T, Quirion R, Rochford J, Srivastava LK.
NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition
of startle. Neuroreport 1998;9:461–466. [PubMed: 9512390]
Cox et al. Page 12














Representative Western blots of GAPDH, NCAM-180, -140, -120, PSA-NCAM (polysialic
acid-NCAM), NCAM-EC (extracellular cleaved NCAM), and NCAM-IC (intracellular
cleaved NCAM) in human prefrontal cortex (areas 9/46) across development. An equal amount
of total protein homogenate was loaded to each lane for each respective protein. Lanes 1–7
contained one subject from each of the following age groups: fetal, 0–12 mos (months), 1–5
yrs (years), 6–10 yrs, 11–15 yrs, 16–20 yrs, and 21–25 yrs; lane 8 contained a pooled sample
applied to all gels. Protein bands are marked with molecular weights (MW) in kilodaltons
(kDa). The NCAM-180, -140, -120 gel shows immunoreactive bands at 180, 140 and 120 kDa
at all ages except in the fetal group for NCAM-120. Consistent with other studies of NCAM
in human brain, several weaker bands are also seen between 180 and 140 kDa, likely
representing isoforms of NCAM-180. The NCAM-EC gel shows the 105–115 kDa band
representing NCAM-EC and a band at 120 kDa representing NCAM-120 in most postnatal
samples.
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GAPDH in prefrontal cortex did not demonstrate an effect of age by ANOVA (F=1.242, df=6,
41, p=0.309) from mid-gestation through early adulthood by Western blot. Error bars reflect
standard deviations.
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NCAM-180, -140, and -120 protein(GAPDH normalized) measured by Western blot in human
prefrontal cortex spanning from fetal to early adult ages. Post hoc Tukey’s multiple comparison
testing demonstrated changes at p<0.05 (*), p<0.01 (**) and p<0.001 (***) significance levels,
as indicated. (A) NCAM-180 showed a significant effect of age by ANOVA (F=3.674, df=6,
41, p=0.0062). NCAM-180 was higher in the fetal group compared to the 1–5 and 21–25 year
groups (*). (B) NCAM-140 demonstrated an effect of age by ANOVA (F=6.497, df=6, 41,
p<0.0001). Compared to the 0–12 months (mos) age group, NCAM-140 was lower in the 11–
15 year (*), 6–10 and 16–20 year (**), and in the 1–5 and 21–25 year (***) groups. (C)
NCAM-120 demonstrated an effect of age by ANOVA (F=5.311, df=6, 41, p=0.0006).
NCAM-120 in the fetal group was lower than in the 6–10 and 21–25 year (*), 0–12 mos (**)
and 11–15 year (***) groups.
Cox et al. Page 15














PSA-NCAM (polysialic acid-NCAM) in prefrontal cortex showed a strong effect of age by
ANOVA (F=20.57, df=6, 41, p<0.0001) as measured by Western blot (GAPDH normalized).
Fetal PSA-NCAM was from 5- to 30-fold higher compared to each of the postnatal groups
(***p<0.001).
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(A) NCAM-EC (extracellular cleaved NCAM) in prefrontal cortex showed an effect of age by
ANOVA (F=7.264, df=6, 41, p<0.0001) as measured by Western blot (GAPDH normalized).
NCAM-EC in the fetal samples was lower compared to the 16–20 year (*p<0.05) and 6–10,
11–15, and 21–25 year (***p<0.001) groups. (B) NCAM-IC (intracellular cleaved NCAM) in
prefrontal cortex showed an effect of age by ANOVA (F=8.529, df=6, 41, p<0.0001) by
Western blot (GAPDH normalized). NCAM-IC in the 0–12 mos (months) group was higher
than in each of the older age groups (***p<0.001). (C) Scatterplot of NCAM-140 versus
NCAM-EC in all cortical samples. A linear regression analysis between the two variables was
not statistically significant (F=1.68, p=0.202, R-square=0.0404). (D) Scatterplot of
NCAM-180 versus NCAM-EC in all cortical samples. A linear regression analysis between
the two variables was not statistically significant (F=2.22, p=0.144, R-square=0.05254).
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A summary figure of normalized NCAM species in human cortical development. These
smoothed lines allow for a qualitative comparison of changes in each of the normalized NCAM
species relative to each other from mid-gestation into early adulthood.
Cox et al. Page 18















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Neuroscience. Author manuscript; available in PMC 2010 August 4.
